about
An update on the use of transdermal oxybutynin in the management of overactive bladder disorderUse of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the LiteratureThe impact of body mass index on renal functional outcomes following minimally invasive partial nephrectomy.Assessing variability of the 24-hour pad weight test in men with post-prostatectomy incontinence.Underactive bladder in women: is there any evidence?Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation.Phenotyping women with detrusor underactivity by presumed etiology: Is it plausible?Urinary retention in elderly women: diagnosis & management.Robot-assisted Laparoscopic Augmentation Ileocystoplasty and Mitrofanoff Appendicovesicostomy in Children: Updated Interim Results.Urinary incontinence in women: non pharmacologic approaches and newer pharmacotherapies. An update.Pharmacologic management of non-neurogenic functional obstruction in women.Management of Voiding Dysfunction After Female Neobladder Creation.Urinary retention and catheter use among U.S. female Medicare beneficiaries: Prevalence and risk factors.Evaluation of the axonics modulation technologies sacral neuromodulation system for the treatment of urinary and fecal dysfunction.Treatment of Pelvic Floor Disorders Following Neobladder.Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.Evaluation of robotic-assisted laparoscopic and open pyeloplasty in children: single-surgeon experienceCystectomy and urinary diversion as management of treatment-refractory benign disease: the impact of preoperative urological conditions on perioperative outcomes.Regulation of intracellular pH mediates Bax activation in HeLa cells treated with staurosporine or tumor necrosis factor-alpha.Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma.The impact of running versus interrupted anastomosis on ureterointestinal stricture rate after radical cystectomy.A 26-year-old woman with weight loss and a renal mass.Health literacy, cognition, and urinary incontinence among geriatric inpatients discharged to skilled nursing facilities.Prospective health-related quality of life analysis for patients undergoing radical cystectomy and urinary diversion.Reply: To PMID 25109560.Can urologic oncologists help expand the renal donor pool with “restored” kidneys?Financial implications of surgical complications in pediatric liver transplantationIncremental Costs of Post–Liver Transplantation ComplicationsFinancial Implications of Pancreas Transplant Complications: A Business Case for Quality ImprovementThe prognostic significance of perineural invasion and race in men considering active surveillanceBuccal mucosal graft urethroplasty for the treatment of urethral stricture in the neophallusEditorial Comment
P50
Q26749105-F0C47EDA-3D9A-44F8-9CC7-08F8E80D4F58Q26749613-EEC7354A-E15A-4ED0-A08A-B04C302D9223Q35245860-E34AC28F-785A-4206-83A5-D49B9F371FC4Q36912801-611CDDF3-F4DE-4753-BD7B-42763C68BDC0Q36968506-7A4E42B5-3CEC-4486-BD4A-DCCD7F7B48FAQ37564393-6E7FD5F9-44B2-4357-AAC5-FDAA15EB2F5FQ37609192-5ABCAB40-36B0-4008-B12F-83962A806828Q38252391-CE72A393-3927-49EC-88A1-90317C2FCE0FQ38549740-0143E5B3-98DA-4365-8BDB-302DA80289FFQ38769654-BB618AEF-7142-41EC-B21E-DF26DAE05526Q38812355-B17D364A-565C-49FF-A0C1-87884FDCC71DQ38913828-DFB9EA25-1CB9-4A21-AB67-98C59821B35FQ38924685-4398D0BF-5062-49F9-9430-D818CB003595Q39028663-29F613CA-6541-440E-BD48-EDBE7668316BQ39108641-7FA5BBD9-4409-4E72-8001-A284624ACF82Q40459374-6EA4449A-4295-470C-B21B-5DDA6DDC64B8Q41340305-8E673B26-56C9-47E0-A51B-FD6A552F93E5Q44145652-2ACC8EDD-E102-47CE-9CA7-E643EBAB3B78Q44189931-9758E6A8-8995-4E88-9188-948D0E522073Q44248922-258BA024-676F-4336-B4C0-1753D616591BQ45055946-92E4D843-CCE8-4795-8FB8-E69C1F295D6CQ47356051-7E95E955-B5D1-42CF-B1C8-F9FAF27FBD6DQ47656543-B08E6FA2-34BF-4BA9-92AF-A1093CFF2716Q48068728-C2D1CCC0-544F-4D1F-A5B7-AF5F4C860743Q48068730-8A65E87B-7170-4121-B18E-2ACA9118C491Q57653138-88984F8F-737F-4F37-8EFC-9AB6435FA0EEQ57653144-5EB76FF3-ED66-4B97-ADA0-3F9B6D6EA304Q57653148-B57DE8A1-C809-4F32-BF02-B0C40CCE530DQ57653155-A6CC154C-A140-4501-B3A9-BB5055BC85DCQ86494647-94066AE7-DF57-4A15-947A-DB2A13675AB3Q86728385-80AECBF5-3308-41E3-A2F9-70A9893214D1Q95515339-356FCA66-11AF-413C-897C-899D04F23D95
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joshua A Cohn
@ast
Joshua A Cohn
@en
Joshua A Cohn
@es
Joshua A Cohn
@nl
type
label
Joshua A Cohn
@ast
Joshua A Cohn
@en
Joshua A Cohn
@es
Joshua A Cohn
@nl
prefLabel
Joshua A Cohn
@ast
Joshua A Cohn
@en
Joshua A Cohn
@es
Joshua A Cohn
@nl
P106
P31
P496
0000-0002-4953-3321